Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 2/20 | 0.44 |
| ▸ | RXRB | P28702 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL379060 | 0.95 | ELANE (0.51) | ELANERXRARXRBCYP3A4LMNA | |
| SCHEMBL30833342 | 0.90 | ELANE (0.55) | ELANERXRARXRB | |
| SCHEMBL16820804 | 0.90 | ELANE (0.55) | ELANERXRARXRB | |
| SCHEMBL2122878 | 0.89 | ELANE (0.54) | ELANERXRARXRBLMNAKMT2A | |
| SCHEMBL2123474 | 0.86 | ELANE (0.48) | ELANERXRARXRBLMNAKMT2A | |
| SCHEMBL19186955 | 0.86 | ELANE (0.44) | ELANERXRARXRBCYP3A4LMNA | |
| SCHEMBL218655 | 0.86 | ELANE (0.56) | ELANECYP3A4LMNAKMT2AATM | |
| SCHEMBL17625859 | 0.83 | ELANE (0.42) | ELANERXRARXRBCYP3A4LMNA | |
| SCHEMBL11938793 | 0.83 | ELANE (0.46) | ELANERXRARXRBLMNA | |
| SCHEMBL378966 | 0.83 | POLB (0.50) | ELANERXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2280032-B1 | PHOTOPOLYMERIZABLE COMPOSITIONS | TOKUYAMA DENTAL CORP (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8394869-B2 | Photopolymerizable compositions useful as a dental restorative material | TOKUYAMA DENTAL CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-20110172323-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS | TOKUYAMA DENTAL CORPORATION (JP) | 2011-07-14 | — | — | US | disclosed |
| EP-2280032-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS | Tokuyama Dental Corporation (JP) | 2011-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172323-A1 | PHOTOPOLYMERIZABLE COMPOSITIONS | RARA, RARB, RARG | ELANE 3939/4885RXRA 43/4885RXRB 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.